Dr. Reddy’s Laboratories Acquires Progynova and Cyclo-Progynova Trademarks from Mercury Pharma Group
Key Highlights: Implications: Dr. Reddy’s gains immediate leadership in the estradiol segment, leveraging its physician network to rapidly expand gynecology prescriptions...
Key Highlights: Implications: Dr. Reddy’s grabs monopoly control over Hepatitis E prevention, dominating public health tenders and private vaccination drives as awareness explo...
